Protamine-induced acute thrombosis in a post-TAVR patient: A word of caution.

Protamine-induced acute thrombosis in a post-TAVR patient: A word of caution. - 2022

Available in print through MWHC library: 2002 - present

Major vascular complications after transcatheter aortic valve replacement (TAVR) are a pertinent issue and associated with increased morbidity and mortality. We herein describe a case of acute limb ischemia following the administration of protamine sulfate (PS) that was administered to mitigate a bleeding complication post-failure of a vascular access closure device. PS should be used cautiously for the prevention or management of bleeding-site complications following TAVR. The patient described in this case has consented to having his case described in this manuscript. Copyright © 2022. Published by Elsevier Inc.


English

1878-0938

10.1016/j.carrev.2022.06.008 [doi] S1553-8389(22)00300-1 [pii]


IN PROCESS -- NOT YET INDEXED


MedStar Heart & Vascular Institute
MedStar Washington Hospital Center
MedStar Washington Hospital Center


Internal Medicine Residency
Interventional Cardiology Fellowship


Case Reports

Powered by Koha